"Rothman Orthopaedic Institute is a world-leader in the field of orthopaedics serving communities in Pennsylvania, New Jersey, New York and most recently Florida through its new partnership with AdventHealth. Rothman Orthopaedics provides high-quality, compassionate and affordable musculoskeletal care that is grounded in evidence-based medicine. Rothman Orthopaedic Institute is recognized for excellence in clinical treatment methods, research, education and technology with experts in nine orthopaedic sub-specialties including spine, hip and knee, foot and ankle, shoulder and elbow, hand and wrist, sports medicine, physical medicine and rehabilitation, orthopaedic oncology and trauma. For more information please call 800-321-9999."

During the past decade, Rothman Institute conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 11 clinical trials were completed, i.e. on average, 26.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rothman Institute" #1 sponsor was "Rothman Institute Orthopaedics" with 36 trials, followed by "Zimmer Biomet" with 12 trials sponsored, "Smith & Nephew, Inc." with 6 trials sponsored, "BioMimetic Therapeutics" with 3 trials sponsored and "Rush University Medical Center" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rothman Institute" #1 collaborator was "Rothman Institute Orthopaedics" with 2 trials as a collaborator, "Stryker Orthopaedics" with 2 trials as a collaborator, "3M" with 1 trials as a collaborator, "American Association of Hip and Knee Surgeons" with 1 trials as a collaborator and "Clinical Advances Through Research and Information Translation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Rothman Institute" are "Osteoarthritis" (11 trials), "Rheumatoid Arthritis" (9 trials), "Degenerative Arthritis" (4 trials), "Avascular Necrosis" (3 trials) and "Osteo Arthritis Knee" (3 trials). Many other conditions were trialed in "Rothman Institute" in a lesser frequency.

Most popular intervention types in "Rothman Institute" are "Device" (41 trials), "Procedure" (14 trials), "Drug" (13 trials), "Other" (11 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Standard of Care" (3 trials), "Anterior Cervical Discectomy and Fusion (ACDF)" (2 trials), "PCM Cervical Disc" (2 trials), "Placebo" (2 trials) and "500mg of Acetaminophen every 6 hours as needed for pain" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rothman Institute" are 78 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rothman Institute". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Rothman Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Rothman Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 52 trials that are defined as “Not Applicable".